Repositioning Molecules of Chinese Medicine to Targets of SARS-Cov-2 by Deep Learning Method

被引:7
|
作者
Song, Tao [1 ,2 ]
Zhong, Yue [1 ]
Ding, Mao [3 ]
Zhao, Renteng [4 ]
Tian, Qingyu [1 ]
Du, Zhenzhen [1 ]
Liu, Dayan [1 ]
Liu, Jiali [1 ]
Deng, Yufeng [1 ]
机构
[1] China Univ Petr East China, Coll Comp Sci & Technol, Qingdao 266580, Peoples R China
[2] Univ Politecn Madrid, Fac Comp Sci, Dept Artificial Intelligence, Campus Montegancedo, Madrid 28660, Spain
[3] Shandong Univ, Hosp 2, Dept Intens Care Unit, Jinan 250033, Peoples R China
[4] Trinity Earth Technol Co Ltd, Mumbai, Maharashtra, India
基金
中国国家自然科学基金;
关键词
SARS-CoV-2; Chinese medicine; deep convolutional neural network; drug reposition; SYSTEMS;
D O I
10.1109/BIBM49941.2020.9313151
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Traditional Chinese medicine has been used to treat and prevent infectious diseases for thousands of years, and has accumulated a large number of effective prescriptions. Deep learning methods provide powerful applications in calculating interactions between drugs and targets. In this study, we try to use the method of deep learning to reposition molecules of Chinese medicines (CMs) and the targets of syndrome coronavirus 2 (SARS-CoV-2). A deep convolution neural network with residual module (DCNN-Res) is constructed and trained on KIBA dataset. The accuracy of predicting the binding affinity of drug-target pairs is 85.33%. By ranking binding affinity scores of 433 molecules in 35 CMs to 6 targets of SARS-Cov-2, DCNN-Res recommends 30 possible repositioning molecules. The consistency between our result and the latest research is 0.827. The molecules in Gancao and Huangqin have a strong binding affinity to targets of SARS-CoV-2, which is also consistent with the latest research.
引用
收藏
页码:2306 / 2312
页数:7
相关论文
共 50 条
  • [41] SCV Filter: A Hybrid Deep Learning Model for SARS-CoV-2 Variants Classification
    Wang, Han
    Gao, Jingyang
    CURRENT BIOINFORMATICS, 2024, 19 (05) : 434 - 445
  • [42] SARS-CoV-2 becoming more infectious as revealed by algebraic topology and deep learning
    Chen, Jiahui
    Wang, Rui
    Wei, Guo-Wei
    COMMUNICATIONS IN INFORMATION AND SYSTEMS, 2021, 21 (01) : 31 - 36
  • [43] A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
    Jo, Seri
    Kim, Suwon
    Yoo, Jahyun
    Kim, Mi-Sun
    Shin, Dong Hae
    MICROORGANISMS, 2021, 9 (04)
  • [44] Existence of SARS-CoV-2 Entry Molecules in the Oral Cavity
    Sakaguchi, Wakako
    Kubota, Nobuhisa
    Shimizu, Tomoko
    Saruta, Juri
    Fuchida, Shinya
    Kawata, Akira
    Yamamoto, Yuko
    Sugimoto, Masahiro
    Yakeishi, Mayumi
    Tsukinoki, Keiichi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 16
  • [45] In silicoinvestigation of spice molecules as potent inhibitor of SARS-CoV-2
    Rout, Janmejaya
    Swain, Bikash Chandra
    Tripathy, Umakanta
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (02): : 860 - 874
  • [46] Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches
    Abbasi, Bilal Ahmed
    Saraf, Devansh
    Sharma, Trapti
    Sinha, Robin
    Singh, Shachee
    Sood, Shriya
    Gupta, Pranjay
    Gupta, Akshat
    Mishra, Kartik
    Kumari, Priya
    Rawal, Kamal
    PEERJ, 2022, 10
  • [47] SARS-CoV-2
    Steinbauer, M.
    Boeckler, D.
    GEFASSCHIRURGIE, 2020, 25 (06): : 387 - 388
  • [48] A Precision Medicine Approach to SARS-CoV-2 Pandemic Management
    Carlos D. Crisci
    Ledit R. F. Ardusso
    Antonela Mossuz
    Leila Müller
    Current Treatment Options in Allergy, 2020, 7 : 422 - 440
  • [49] SARS-CoV-2
    Wallet, France
    ENVIRONNEMENT RISQUES & SANTE, 2021, 20 (03): : 330 - 333
  • [50] German reproductive medicine in times of the SARS-CoV-2 pandemic
    Findeklee S.
    Döhmen G.
    Döhmen C.
    MMW - Fortschritte der Medizin, 2021, 163 (2) : 52 - 55